| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382468A1 A method for decreasing foam formation during cultivation of trichoderma |
| 03/01/2001 | CA2382462A1 Enzymatic synthesis of deoxyribonucleosides |
| 03/01/2001 | CA2382184A1 Novel yeast mutants and process for producing glycoprotein containing mammalian type sugar chain |
| 03/01/2001 | CA2382183A1 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | CA2382146A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381755A1 Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
| 03/01/2001 | CA2381710A1 D-gluconolactone oxidase gene and method for producing recombinant d-gluconolactone oxidase |
| 03/01/2001 | CA2381206A1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 03/01/2001 | CA2376406A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | CA2376404A1 Meg-1 protein |
| 03/01/2001 | CA2348161A1 Process for producing coenzyme q10 |
| 03/01/2001 | CA2344469A1 Pesticidal proteins |
| 03/01/2001 | CA2315978A1 New nucleotide sequences coding for the thre gene and process for the enzymatic production of l-threonine using coryneform bacteria |
| 02/28/2001 | EP1078991A2 Methods for producing L-amino acids |
| 02/28/2001 | EP1078989A2 Method for producing L-glutamic acid by fermentation accompanied by precipitation |
| 02/28/2001 | EP1078983A1 Sorbitol dehydrogenase, microorganisms for producing the same, process for the production thereof, and method for the measurement of sorbitol |
| 02/28/2001 | EP1078097A1 Cell-free chimeraplasty and eukaryotic use of heteroduplex mutational vectors |
| 02/28/2001 | EP1078082A1 Enzymatically-active recombinant human beta-tryptase and method of making same |
| 02/28/2001 | EP1078081A2 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 02/28/2001 | EP1078080A1 Methods for producing polypeptides in filamentous fungal mutant cells |
| 02/28/2001 | EP1078078A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages |
| 02/28/2001 | EP1078077A1 Nucleic acids and proteins from pineapple stem |
| 02/28/2001 | EP1078076A2 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase |
| 02/28/2001 | EP1078075A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 02/28/2001 | EP1078074A2 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity |
| 02/28/2001 | EP1078073A1 Chitinase chitin-binding fragments |
| 02/28/2001 | EP1078069A2 Improved in vivo production of cephalosporins |
| 02/28/2001 | EP1078068A2 Polyhydroxyalkanoate biopolymer compositions |
| 02/28/2001 | EP1078067A2 Bacillus thuringiensis toxins and genes for controlling coleopteran pests |
| 02/28/2001 | EP1078065A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078064A2 Compounds from moraxella catarrhalis |
| 02/28/2001 | EP1078063A2 Basb029polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/28/2001 | EP1078062A2 Growth-associated protease inhibitor heavy chain precursor |
| 02/28/2001 | EP1078057A2 Cell signaling proteins |
| 02/28/2001 | EP1078056A1 Rhotekin, a putative target for rho |
| 02/28/2001 | EP1078054A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 02/28/2001 | EP1078046A1 97 human secreted proteins |
| 02/28/2001 | EP1077999A2 Moraxella catharralis proteins |
| 02/28/2001 | EP1077996A1 HUMAN EDG3sb GENE |
| 02/28/2001 | EP1077989A1 Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene |
| 02/28/2001 | EP1077983A2 Pria |
| 02/28/2001 | EP0672142B1 Multivalent and multispecific binding proteins, their manufacture and use |
| 02/28/2001 | EP0594710B1 Tyrosine kinase |
| 02/28/2001 | EP0584284B1 Recombinant dna-derived cholera toxin subunit analogs |
| 02/28/2001 | EP0576621B1 Ethanol production by recombinant hosts |
| 02/28/2001 | EP0548165B1 Expression of g protein coupled receptors in yeast |
| 02/28/2001 | CN1285873A orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof |
| 02/28/2001 | CN1285870A Novel pectate lyases |
| 02/28/2001 | CN1285869A Microorganism, method for obtaining same and feed additive |
| 02/28/2001 | CN1285846A Detection systems for registering protein interactions and functional relationships |
| 02/28/2001 | CN1285717A Flavouring material from yeast extracts |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/28/2001 | CN1285411A Acetyl-tyrothricin and process for preparing 5-fluorouridine using same as enzyme precursor |
| 02/28/2001 | CN1285409A Blue-green alga shuttle plasmid expression vector and method for expressing thymison 'alpha' 1 |
| 02/28/2001 | CN1285408A Blue-green alga transgene by using gene integration platform system and method for expressing thymosin 'alpha'1 |
| 02/28/2001 | CN1285407A Heat shock induction exogenous gene high-efficient expressed blue-green alga transgenic expression system and the method for expressing thymosin 'alpha'1 |
| 02/28/2001 | CN1285400A White cordycepin and productive technology thereof |
| 02/28/2001 | CN1285187A Bdellovibrio bacteriophagic freeze-dryied powder preparation and productive method thereof |
| 02/28/2001 | CN1062598C Construction method of mura lead mycillin of clone with salmon thyrocal citonin gene |
| 02/28/2001 | CN1062481C Inhibitor HTV activity |
| 02/27/2001 | US6194557 Nucleic acid molecules encoding Bap-1 proteins |
| 02/27/2001 | US6194546 Influenza virus haemagglutinin which has a heterologous epitope at antigenic site a; vaccines against foot-and-mouth disease, poliovirus, human rhinovirus, hepatitis b virus, plasmodium and bacteria |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/27/2001 | US6194200 Expression systems for preparation of polypeptides in prokaryotic cells |
| 02/27/2001 | US6194197 Bioremediation of xenobiotics including methyl tert-butyl ether |
| 02/27/2001 | US6194194 Method for controlling dreissena species |
| 02/27/2001 | US6194193 Nutrient plant formulation with microbial strains |
| 02/27/2001 | US6194190 From pyrococcus which can release two or more blocking groups selected from acetyl group, pyroglutamyl group, formyl group and myristoyl group, from protected peptides; use in kits for analyzing an amino acid sequence |
| 02/27/2001 | US6194187 Apoptosis-inducing protein and gene encoding the same |
| 02/27/2001 | US6194186 Human protein kinase and kinase inhibitors |
| 02/27/2001 | US6194185 Recombinant materials and methods for production of limonene hydroxylases |
| 02/27/2001 | US6194183 Preparing polypeptide for use in surfactants; providing transformed phage, incubate with surfactants to deactivate polypeptide, separate phage that display variant polypeptides, isolated phage sequences of variant and determine sequence |
| 02/27/2001 | US6194181 Producing epothiolones in a culture medium by providing microorganisms such as myxobacteria which produce epothiolones, and adding a complex-forming agent soluble in the culture medium, such as cyclodextrins; antitumor agents |
| 02/27/2001 | US6194174 Histidine kinase, 636 HK, of staphylococcus aureus |
| 02/27/2001 | US6194172 Cytokine designated lerk-6 |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194159 Facile method for identifying regulated promoters |
| 02/27/2001 | US6194152 Nucleotide sequences for the diagnosis and treatment of human urogenital cancers |
| 02/27/2001 | US6194140 HCV NS3 protein fragments having helicase activity and improved solubility |
| 02/27/2001 | US6194136 Cryoprotective solutions comprising DMSO, PG, 2,3-butanediol,raffinose and PVP |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | US6193964 Strain of streptomyces, and relevant uses thereof |
| 02/27/2001 | CA2195784C Fumonisin-detoxifying enzymes |
| 02/27/2001 | CA2025598C Chimaeric hepadnavirus core antigen proteins |
| 02/27/2001 | CA1341192C Process for the preparation of a protein by yeasts using an inducible system, corresponding vectors and transformed strains |
| 02/22/2001 | WO2001013117A2 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 02/22/2001 | WO2001012845A1 Screening for udp-glucose: glycoprotein glucosyltransferase (uggt) activity |
| 02/22/2001 | WO2001012833A2 Process for the biological production of 1,3-propanediol |
| 02/22/2001 | WO2001012827A2 Method for production of transgenic plants with increased tocopherol content |
| 02/22/2001 | WO2001012822A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 02/22/2001 | WO2001012821A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012814A1 Ml-236b biosynthesis-associated dna |
| 02/22/2001 | WO2001012813A1 Gene encoding merozoite protein of babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012808A1 Novel frizzled family genes 584 |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |